
Eli Lilly hits $1 trillion market value, a first for a health-care company
Continue reading The Power of A Patent
Eli Lilly hits $1 trillion market value, a first for a health-care company
Continue reading The Power of A Patent
Data Marketing challenged a Department of Labor (“DOL”) advisory opinion that finds the arrangement is not an ERISA plan and states are free to regulate it. In 2019, Data Marketing sued the DOL in the Northern District of Texas and emerged victorious.
Continue reading Data Marketing Poses Significant Implications for Health Plans